Company intelligence / Profile preview

ZPD

Ownership: Private
Development stage: Other

Overview

ZPD A/S manufactures high-purity, GMP-certified chondroitin sulfate sodium for use in pharmaceutical, nutraceutical, food supplement, and animal nutrition markets. Their product meets European Pharmacopoeia standards and has received the Chemical and TSE Certificate of Suitability from EDQM. The company emphasizes traceability of raw materials to ensure safety and quality. No clinical trial results are published by the company itself since it supplies ingredients rather than finished drugs.

Therapeutic areas: Rheumatology
Modalities: Biologic (Chondroitin sulfate sodium)Small molecule (as chondroitin sulfate can be considered a small molecule polysaccharide in some regulatory contexts)
Industry: Chemicals & Materials

Beyond the preview

Go deeper on ZPD.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZPD.

Explore the full profile